Filamentous occlusion of the Middle cerebral artery is a common model for studying ischemic stroke in mice.
Stroke is among the most frequent causes of death and adult disability, especially in highly developed countries. However, treatment options to date are very limited. To meet the need for novel therapeutic approaches, experimental stroke research frequently employs rodent models of focal cerebral ischaemia. Most researchers use permanent or transient occlusion of the middle cerebral artery (MCA) in mice or rats.
Proximal occlusion of the middle cerebral artery (MCA) via the intraluminal suture technique (so called filament or suture model) is probably the most frequently used model in experimental stroke research. The intraluminal MCAO model offers the advantage of inducing reproducible transient or permanent ischaemia of the MCA territory in a relatively non-invasive manner. Intraluminal approaches interrupt the blood flow of the entire territory of this artery. Filament occlusion thus arrests flow proximal to the lenticulo-striate arteries, which supply the basal ganglia. Filament occlusion of the MCA results in reproducible lesions in the cortex and striatum and can be either permanent or transient. In contrast, models inducing distal (to the branching of the lenticulo-striate arteries) MCA occlusion typically spare the striatum and primarily involve the neocortex. In addition these models do require craniectomy. In the model demonstrated in this article, a silicon coated filament is introduced into the common carotid artery and advanced along the internal carotid artery into the Circle of Willis, where it blocks the origin of the middle cerebral artery. In patients, occlusions of the middle cerebral artery are among the most common causes of ischaemic stroke. Since varying ischemic intervals can be chosen freely in this model depending on the time point of reperfusion, ischaemic lesions with varying degrees of severity can be produced. Reperfusion by removal of the occluding filament at least partially models the restoration of blood flow after spontaneous or therapeutic (tPA) lysis of a thromboembolic clot in humans.
In this video we will present the basic technique as well as the major pitfalls and confounders which may limit the predictive value of this model.
To guarantee high quality and reproducibility, we recommend the use of Standard Operating Procedures (SOP). In this video, published SOPs as developed and used in our laboratory are applied. 1
1. Middle Cerebral Artery Occlusion
2. Sham Operation
3. Preparation of the Filament
4. Representative Results
Depending on the duration of blood flow restriction, different motor and behavioural deficits result. Both after 30 and 60 min of cerebral ischaemia, animals in most cases show decreased resistance to lateral push and circling due to disturbance in locomotion. Milder lesions manifest as a flexor position in the front limbs. These easily observable signs can be used as a basic score for the success of the operation.2
Morphologically the lesion can be assessed using either histology or Magnetic Resonance Imaging (MRI). Sixty minutes occlusion of the middle cerebral artery produces tissue pannecrosis in an area including both the striatum and the neocortex, whereas 30 minutes of ischaemia cause mainly neuronal cell death limited to the striatum. 3 ( Figure 2) In terms of infarct volume, we expect a standard deviation lower than 30% in a set of operations. Mortality depends on the occlusion time with around 5 % after 30 min of ischaemia and 10 – 20 % after 60 min.
Another minimal invasive possibility is the use of Laser Doppler flowmetry (LDF) during the operation, which allows a direct control of its success. In an individual animal, reduction to 10 – 20 % of preocclusion values clearly indicates successful induction of focal cerebral ischemia. 4 However, LDF cannot be used as a method for interindividual comparisons, since LDF can only measure quantitative changes (in percentages) of blood flow within a small and limited tissue sample volume. It does not give information about the spatial extent of blood flow reduction. 5
There are several tests to assess behavioural aspects after stroke, including gait analysis 6,7, Rotarod 8, Pole test 9,10, adhesive removal test 11,12, staircase test 13,14, ladder rung test15,16 and Morris water maze17. In all these tests, mice subjected to MCAo perform less successfully than control animals.
Figure 1. Scheme of the vessel architecture supplying the brain (depicted in background) in the mouse. Different strains may show variations, for example the occipital artery sometimes leaves from the internal carotid artery.
Figure 2. Schematic illustration of typical lesion sizes after different time points of reperfusion in the proximal MCAo model. In the middle, the typical course of functional activity and cerebral blood flow after MCAo are depicted. (MCAo: Middle cerebral artery occlusion, LDF: Laser Doppler flow measurement)
The model of transient, proximal MCA occlusion18,19 presented here mimics one of the most common types of ischaemic stroke in patients.20 Based on variable reperfusion times, the model offers different grades of damage ranging from transient ischaemic attack (TIA) to large infarcts including major parts of the ischemic hemisphere. This allows the researcher to study different pathophysiological mechanisms after stroke. 20,21
Surgery can be performed in a short time period and produces highly reproducible lesions. Nevertheless, this requires a thorough control of confounders.22 Small differences in operation technique may account for different effects on the infarct.23,24 Furthermore, due to variances in cerebral vascular anatomy, different mouse strains show a different outcome.25,26 Body temperature affects neurological damage, with hypothermia leading to smaller lesions27 and hyperthermia to more severe deficits.28 Accordingly, temperature control and maintenance is highly relevant in this model.29 In addition, blood pressure and blood gases are important confounders of outcome and need to be monitored.30,31 The use of quick and minimal invasive methods (non-invasive blood pressure measurement, suitable and easy accessible blood collection sites) is recommended. The choice of the anaesthetic is also highly important, as some may have neuroprotective effects, and/or be vasodilators, as for example Isoflurane.32 Consequently, exposure to anaesthesia should be as short as possible and standardized. We exclude animals which have undergone surgery for longer than 15 min.
Shaving the surgical site produces microabrasions and inflammation and releases hair fragments. This may further increase inflammation and foster local infection, which may impact on stroke pathophysiology. Housing conditions, especially the use of enrichment, may affect stroke outcome and should be standardized and described in research reports. 6,33,34 The use of environmental enrichment and its effect on reproducibility is a matter of discussion.35 Another important confounder is the stroke induced risk for infection especially after longer times of ischaemia36, which leads to additional morbidity and increased mortality. 37,38 As infections become symptomatic at around day 3 to 5, this has important consequences for long term follow-up in such models.
To produce results relevant for the development of novel treatment strategies for stroke, standardization and quality control is highly important in preclinical translational stroke research. 39 “Good Laboratory Practice” 40,41 mandates:
The authors have nothing to disclose.
This work was funded by the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 201024 and n° 202213 (European Stroke Network). Additional funding was given by the Bundesministerium für Bildung und Forschung (Center for Stroke Research Berlin), and the Deutsche Forschungsgemeinschaft (Exzellenzcluster NEUROCURE).
The authors would like to thank Mareike Thielke (Dep. for Experimental Neurology, Charité Berlin) for the support during the operation and Elke Ludwig (Charité Video Services) for producing the animation.
Material Name | Type | Company | Catalogue Number | Comment |
---|---|---|---|---|
Surgical scissors (skin cut) | FST | 14028-10 | ||
2 Dumont forceps (Medical #5 straight tip) | FST | 11253-20 | ||
Spring scissors (according to Vannas) | FST | 15000-00 | ||
Applying forceps for micro clamps | FST | 00072-14 | ||
Micro vascular clamp (e.g. S&G B1-V) | FST | 00396-01 | Also Serrefine possible | |
2 Hemostats according to Hartmann | FST | 13002-10 | ||
Needle holder (according Olsen-Hegar or other) | FST | 12002-14 | ||
Standard anatomical forceps (for wound closure) | FST | 11000-12 | ||
5/0 sutures | Suprama | for vascular ligatures | ||
6/0 sutures | Suprama | for skin suture, 5/0 also possible | ||
Lidocaine (e.g. Xylocain Gel 2%) | Astra Zeneca | or other local pain relief | ||
Dissecting microscope (stereo microscope), magnification 6x to max. 40x | Leica Zeiss | MZ6 Stemi2000C | ||
Cold light source | Leica | KL1500 | ||
Temperature feedback controlled heating pad system | FST | 21052-00 | With mouse pad and small probe | |
Anaethesia system for isoflurane | ||||
Isoflurane | Abott | |||
Veterinary Recovery Chamber | Peco Services | V1200 | Heated cage | |
8.0 nylon filament | Suprama | TEL181005 | for coating | |
Scalpel | For cutting filament in pieces | |||
Ruler | To cut correct length of filament | |||
Xantopren M Mucosa | Heraeus Kulzer | |||
Activator Universal Plus | Heraeus Kulzer | Optosil – Xantopren | ||
2 Dumont forceps (Medical #5 straight tip) | FST | 11253-20 | ||
A soft underlay for storing and grasping the uncoated filaments | e.g. swabs, foam, … | |||
Receptacle for new build filaments | e.g. petri dish, flexible foam,… |